Comparative Dose- and Time-Dependent Manner of Resveratrol on Human Epithelial Cell Types

Revista Brasileira de Farmacognosia - Tập 32 - Trang 466-471 - 2022
Wan Nuramiera Faznie Wan Eddis Effendy1, Rabiatul Basria S. M. N. Mydin1, Kalakotla Shanker2, Kah Yan Ng3, Priya Sundaraju4,5, Sharenia Gunasagaran4,5, Syafiqa Farhana Ahmad Sopian6, Amirah Mohd Gazzali7
1Department of Biomedical Science, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Malaysia
2Department of Pharmacognosy and PhytoPharmacy, Jagadguru Sri Shivarathreeshwara College of Pharmacy, Jagadguru Sri Shivarathreeshwara Academy of Higher Education and Research, Nilgiris, India
3Faculty of Medicine, Imperial College London, London, UK
4Faculty of Health Sciences, Sultan Zainal Abidin University, Gong Badak Campus, Terengganu, Malaysia
5Faculty of Science and Mathematics, Sultan Idris Education University, Tanjong Malim, Malaysia
6Faculty of Applied Sciences, Universiti Teknologi MARA, Arau, Malaysia
7School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia

Tóm tắt

Resveratrol is a conventional nutraceutical compound that has been extensively studied for therapeutic applications, especially cancer therapy; however, its positive therapeutical proprieties are balanced by its negative effects. Presently, the therapeutic functionalities of resveratrol for nasopharyngeal carcinoma, osteosarcoma, and human embryonic cell lines, in terms of optimum dose and time profile, were determined. Epithelial cancer cells originating from the nasopharynx (C666-1, NPC/HK-1), bone (SaOS-2), and kidney (HEK 293) were extensively studied in the current work. NPC cells were exposed to various concentrations of resveratrol (0.16–20.00 μM), individually. Meanwhile, SaOS-2 and HEK 293 were treated with resveratrol of 3.125–200 μM in concentration. The half-maximal inhibitory effect of resveratrol was spectrophotometrically measured at 490 nm. The dose-dependent evaluation showed the inhibitory effect of resveratrol on NPC cell lines while increasing cell proliferation on SaOS-2 and HEK-293 cell lines. After 48 h of incubation, the IC50 value of the NPC cell lines was approximately 3.75 μM for C666-1 and NPC/HK-1. By contrast, the multiplication growth of SaOS-2 and HEK 293 was more than 300% at increased resveratrol concentration. These results depict the enhanced double effect of resveratrol and its potential use in cancer therapy which effectiveness should be further investigated.

Tài liệu tham khảo

Berman AY, Motechin RA, Wiesenfeld MY, Holz MK (2017) The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol 1:35. https://doi.org/10.1038/s41698-017-0038-6 Brown K, Aburido G, Britton RG, Pezzuto JM, Vang O (2020) Resveratrol for cancer prevention: current gaps and opportunities. In: Pezzuto J, Vang O (eds) Natural products for cancer chemoprevention. Springer, Cham. https://doi.org/10.1007/978-3-030-39855-2_2 Cai Y, Zhao L, Qin Y, Zhang M, He Y (2015) Resveratrol inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cell line C666-1 through AMPK activation. Pharmazie 70:399–403. https://doi.org/10.1691/ph.2015.4815 Chen G, Xia H, Zhang ZG, Yu HL (2019) Resveratrol in management of bone and spinal cancers. Nat Prod Res 33:516–526. https://doi.org/10.1080/14786419.2017.1389936 Chen L, Musa AE (2021) Boosting immune system against cancer by resveratrol. Phytother Res 35:5514–5526. https://doi.org/10.1002/ptr.7189 Fonseca-Santos B, Chorilli M (2020) The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems. Int J Pharm 589:119832. https://doi.org/10.1016/j.ijpharm.2020.119832 Fujimoto A, Sakanashi Y, Matsui H, Oyama T, Nishimura Y, Masuda T, Oyama Y (2009) Cytometric analysis of cytotoxicity of polyphenols and related phenolics to rat thymocytes: potent cytotoxicity of resveratrol to normal cells. Basic Clin Pharmacol Toxicol 104:455–462. https://doi.org/10.1111/j.1742-7843.2009.00386.x Ghani U, Naeem M, Rafeeq H, Imtiaz U, Amjad A, Ullah S, Rehman A, Qasim F (2019) A novel approach towards nutraceuticals and biomedical applications. Sch Int J Biochem 2:245–252. https://doi.org/10.36348/SIJB.2019.v02i10.001 Jarosova V, Vesely O, Doskocil I, Tomisova K, Marsik P, Jaimes JD, Smejkal K, Kloucek P, Havlik J (2020) Metabolism of cis-and trans-resveratrol and dihydroresveratrol in an intestinal epithelial model. Nutrients 12:595–605. https://doi.org/10.3390/nu12030595 Peng L, Jiang D (2018) Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition. PLoS One 13:e0205918. https://doi.org/10.1371/journal.pone.0205918 Rauf A, Imran M, Butt MS, Nadeem M, Peters DG, Mubarak MS (2018) Resveratrol as an anticancer agent: a review. Crit Rev Food Sci Nutr 58:1428–1447. https://doi.org/10.1080/10408398.2016.1263597 Ren B, Kwah MX, Liu C, Ma Z, Shanmugam MK, Ding L, Xiang X, Ho PC, Wang L, Ong PS, Goh BC (2021) Resveratrol for cancer therapy: challenges and future perspectives. Cancer Lett 512:63–72. https://doi.org/10.1016/j.canlet.2021.05.001 Robinson K, Mock C, Liang D (2015) Pre-formulation studies of resveratrol. Drug Dev Ind Pharm 41:1464–1469. https://doi.org/10.3109/03639045.2014.958753 Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PV, Martins N, Sharifi-Rad J (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6:91. https://doi.org/10.3390/biomedicines6030091 Sang Y, Li W, Zhang G (2016) The protective effect of resveratrol against cytotoxicity induced by mycotoxin, zearalenone. Food Funct 7:3703–3715. https://doi.org/10.1039/C6FO00191B Tabrez S, Jabir NR, Adhami VM, Khan MI, Moulay M, Kamal MA, Mukhtar H (2020) Nanoencapsulated dietary polyphenols for cancer prevention and treatment: successes and challenges. Nanomedicine 15:1147–1162. https://doi.org/10.2217/nnm-2019-0398 Tan Y, Wei X, Zhang W, Wang X, Wang K, Du B, Xiao J (2017) Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1. Oncol Rep 37:1833–1841. https://doi.org/10.3892/or.2017.5413 Timm M, Saaby L, Moesby L, Hansen EW (2013) Considerations regarding use of solvents in in vitro cell based assays. Cytotechnology 65:887–894. https://doi.org/10.1007/s10616-012-9530-6 Tsao SW, Tsang CM, Lo KW (2017) Epstein–Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc London B Biol Soc 372:20160270. https://doi.org/10.1098/rstb.2016.0270 Uysal T, Gorgulu S, Yagci A, Karslioglu Y, Gunhan O, Sagdic D (2011) Effect of resveratrol on bone formation in the expanded inter-premaxillary suture: early bone changes. Orthod Craniofac Res 14:80–87. https://doi.org/10.1111/j.1601-6343.2011.01511.x Xiong H, Cheng J, Jiang S, Wen J, Jian Y, Wei L, Zhe Z, Jiang FQ, Peng X (2019) The antitumor effect of resveratrol on nasopharyngeal carcinoma cells. Front Biosci 24:961–970. https://doi.org/10.2741/4761 Yousef M, Vlachogiannis IA, Tsiani E (2017) Effects of resveratrol against lung cancer: in vitro and in vivo studies. Nutrients 9:1231–1244. https://doi.org/10.3390/nu9111231 Zupančič Š, Lavrič Z, Kristl J (2015) Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm 93:196–204. https://doi.org/10.1016/j.ejpb.2015.04.002